About Biomemory
Founded in 2021, Biomemory offers an original solution for DNA data storage, set apart from the competition by its use of long DNA fragments and innovative synthetic biology processes. As opposed to the synthetic chemical and enzymatic solutions, Biomemory is exploring the potential of a third option which consists in using a 100% biological approach.
Advertisement
Here you will find Biomemory
Last viewed contents
Spirea raises £2.4M to develop antibody drug conjugates in cancer - Funding will enable the development of Spirea’s pipeline of antibody drug conjugate therapeutics for the treatment of solid tumours
Spirea Ltd - Harrogate, United Kingdom
LETI Pharma GmbH - Ismaning, Germany
Opening the door to affordable lab-grown beef, cow cells defy aging - A potential game-changer for creating sustainable, ethical meat without the environmental toll of traditional livestock farming
EMD Serono, Inc. - Rockland, USA
Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”
Being fit Protects Against Health Risks Caused by Stress at Work
WIKA strengthens management team with Axel Schwerdtfeger - Process Solutions company division under new leadership
F-star - Wien, Austria
Chemical pollution threatens biodiversity - Scientists say more environmental pollutants should be considered in species protection
CureVac and GSK Enter into Pandemic Preparedness Contract with German Government - Five-year contract enables production of up to 80 million vaccine doses at short notice in case of a public health emergency